Alterations in Adipose Tissue and Adipokines in Heterozygous APE1/Ref-1 Deficient Mice

Overview

Journal Endocrinol Metab (Seoul)

Specialty Endocrinology

Date 2024 Nov 20

PMID 39566547

Authors

Eun-Ok Lee

Hao Jin

Sungmin Kim

Hee Kyoung Joo

Yu Ran Lee

Soo Yeon An

Shuyu Piao

Kwon Ho Lee

Byeong Hwa Jeon

Affiliations

Soon will be listed here.

Abstract

Backgruound: The role of apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) in adipose tissue remains poorly understood. This study investigates adipose tissue dysfunction in heterozygous APE1/Ref-1 deficiency (APE1/Ref-1+/-) mice, focusing on changes in adipocyte physiology, oxidative stress, adipokine regulation, and adipose tissue distribution.

Methods: APE1/Ref-1 mRNA and protein levels in white adipose tissue (WAT) were measured in APE1/Ref-1+/- mice, compared to their wild-type (APE1/Ref-1+/+) controls. Oxidative stress was assessed by evaluating reactive oxygen species (ROS) levels. Histological and immunohistochemical analyses were conducted to observe adipocyte size and macrophage infiltration of WAT. Adipokine expression was measured, and micro-magnetic resonance imaging (MRI) was used to quantify abdominal fat volumes.

Results: APE1/Ref-1+/- mice exhibited significant reductions in APE1/Ref-1 mRNA and protein levels in WAT and liver tissue. These mice also showed elevated ROS levels, suggesting a regulatory role for APE1/Ref-1 in oxidative stress in WAT and liver. Histological and immunohistochemical analyses revealed hypertrophic adipocytes and macrophage infiltration in WAT, while Oil Red O staining demonstrated enhanced ectopic fat deposition in the liver of APE1/Ref-1+/- mice. These mice also displayed altered adipokine expression, with decreased adiponectin and increased leptin levels in the WAT, along with corresponding alterations in plasma levels. Despite no significant changes in overall body weight, microMRI assessments demonstrated a significant increase in visceral and subcutaneous abdominal fat volumes in APE1/Ref-1+/- mice.

Conclusion: APE1/Ref-1 is crucial in adipokine regulation and mitigating oxidative stress. These findings suggest its involvement in adipose tissue dysfunction, highlighting its potential impact on abdominal fat distribution and its implications for obesity and oxidative stress-related conditions.

References

Gordon S, Hamann J, Lin H, Stacey M . F4/80 and the related adhesion-GPCRs. Eur J Immunol. 2011; 41(9):2472-6. DOI: 10.1002/eji.201141715. View

Gu X, Wang L, Liu S, Shan T . Adipose tissue adipokines and lipokines: Functions and regulatory mechanism in skeletal muscle development and homeostasis. Metabolism. 2022; 139:155379. DOI: 10.1016/j.metabol.2022.155379. View

Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View

Castro J, Grune T, Speckmann B . The two faces of reactive oxygen species (ROS) in adipocyte function and dysfunction. Biol Chem. 2016; 397(8):709-24. DOI: 10.1515/hsz-2015-0305. View

Ozaki M, Suzuki S, Irani K . Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase. FASEB J. 2002; 16(8):889-90. DOI: 10.1096/fj.01-0664fje. View

Nguyen T . Adiponectin: Role in Physiology and Pathophysiology. Int J Prev Med. 2020; 11:136. PMC: 7554603. DOI: 10.4103/ijpvm.IJPVM_193_20. View

Lee E, Joo H, Lee Y, Kim S, Lee K, Lee S . Inhibits Adipogenic Transcription Factors during Adipocyte Differentiation in 3T3-L1 Cells. Int J Mol Sci. 2023; 24(4). PMC: 9961804. DOI: 10.3390/ijms24043251. View

Joo H, Lee Y, Park M, Choi S, Park K, Lee S . Mitochondrial APE1/Ref-1 suppressed protein kinase C-induced mitochondrial dysfunction in mouse endothelial cells. Mitochondrion. 2014; 17:42-9. DOI: 10.1016/j.mito.2014.05.006. View

Den Hartog G, Chattopadhyay R, Ablack A, Hall E, Butcher L, Bhattacharyya A . Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia. PLoS Pathog. 2016; 12(1):e1005382. PMC: 4711900. DOI: 10.1371/journal.ppat.1005382. View

10.

Bluher M . Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019; 15(5):288-298. DOI: 10.1038/s41574-019-0176-8. View

11.

Anderson E, Lustig M, Boyle K, Woodlief T, Kane D, Lin C . Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 2009; 119(3):573-81. PMC: 2648700. DOI: 10.1172/JCI37048. View

12.

Jeon B, Irani K . APE1/Ref-1: versatility in progress. Antioxid Redox Signal. 2008; 11(3):571-4. DOI: 10.1089/ars.2008.2223. View

13.

Goossens G . The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2007; 94(2):206-18. DOI: 10.1016/j.physbeh.2007.10.010. View

14.

Bluher M . Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes. 2009; 117(6):241-50. DOI: 10.1055/s-0029-1192044. View

15.

Tell G, Quadrifoglio F, Tiribelli C, Kelley M . The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal. 2008; 11(3):601-20. PMC: 2811080. DOI: 10.1089/ars.2008.2194. View

16.

Du Y, Zhou Y, Yan X, Pan F, He L, Guo Z . APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell Death Differ. 2024; 31(4):431-446. PMC: 11043431. DOI: 10.1038/s41418-024-01270-0. View

17.

Achari A, Jain S . Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int J Mol Sci. 2017; 18(6). PMC: 5486142. DOI: 10.3390/ijms18061321. View

18.

Gurusamy N, Mukherjee S, Lekli I, Bearzi C, Bardelli S, Das D . Inhibition of ref-1 stimulates the production of reactive oxygen species and induces differentiation in adult cardiac stem cells. Antioxid Redox Signal. 2008; 11(3):589-600. PMC: 2933566. DOI: 10.1089/ars.2008.2195. View

19.

Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart A . Leptin and Obesity: Role and Clinical Implication. Front Endocrinol (Lausanne). 2021; 12:585887. PMC: 8167040. DOI: 10.3389/fendo.2021.585887. View

20.

Schwartz M, Seeley R, Zeltser L, Drewnowski A, Ravussin E, Redman L . Obesity Pathogenesis: An Endocrine Society Scientific Statement. Endocr Rev. 2017; 38(4):267-296. PMC: 5546881. DOI: 10.1210/er.2017-00111. View